D
INmune Bio, Inc. INMB
$7.30 -$0.20-2.67% NASDAQ
Recommendation
Prev Close
$7.50
Volume
304,816
Avg Vol (90D)
324,509
Market Cap
$174.08M
Dividend & Yield
--
52-Week Range
$4.32 - $10.70
P/E (TTM)
--
EPS (TTM)
-$1.95
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Analysts Predict 15% Upside For DFAC
5/22/2025 - ETF Channel
INmune Bio (INMB, $7.68) price exceeded its 50-day Moving Average on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
INmune Bio (INMB, $7.86) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 16, 2025
5/17/2025 - Tickeron - Technical Analysis
INmune Bio (INMB, $7.86) price moved above its 50-day Moving Average on May 16, 2025
5/17/2025 - Tickeron - Technical Analysis
INmune Bio (INMB, $7.29) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 15, 2025
5/16/2025 - Tickeron - Stocks
INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity
5/15/2025 - SeekingAlpha
INmune Bio (INMB, $7.43) price exceeded its 50-day Moving Average on May 14, 2025
5/15/2025 - Tickeron - Stocks
INmune Bio (INMB, $7.43) entered Downtrend as Momentum indicator drops below 0 level on May 14, 2025
5/15/2025 - Tickeron - Stocks
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
5/14/2025 - GuruFocus
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
5/14/2025 - Globe Newswire
INmune Bio (INMB, $8.06) price moved above its 50-day Moving Average on May 13, 2025
5/14/2025 - Tickeron - Stocks
INmune Bio (INMB, $8.06) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 13, 2025
5/14/2025 - Tickeron - Stocks
INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript
5/10/2025 - Seeking Alpha: Transcripts
INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript
5/10/2025 - SeekingAlpha
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
5/8/2025 - GuruFocus
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
5/8/2025 - Globe Newswire
INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings
5/7/2025 - GuruFocus
INmune Bio (INMB, $7.13) entered Downtrend as Momentum indicator drops below 0 level on May 06, 2025
5/7/2025 - Tickeron - Stocks
INmune Bio (INMB, $7.13) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 6, 2025
5/7/2025 - Tickeron - Stocks
INmune Bio (INMB, $7.13) Stochastic Oscillator left the oversold zone on May 06, 2025
5/7/2025 - Tickeron - Stocks
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on ...
5/5/2025 - GuruFocus
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
5/5/2025 - Globe Newswire
Renaissance Technologies LLC Increases Position in INmune Bio, Inc. (NASDAQ:INMB)
5/4/2025 - MarketBeat
475,551 Shares in INmune Bio, Inc. (NASDAQ:INMB) Acquired by Raymond James Financial Inc.
5/3/2025 - MarketBeat
INmune Bio (INMB) Expected to Announce Quarterly Earnings on Thursday
5/3/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$50.00K
EBITDA (TTM)
--
EBIT (TTM)
-$41.52M
Net Income (TTM)
-$40.80M
Balance Sheet
Total Assets (Q)
$37.80M
Total Debt (Q)
$347.00K
Total Liabilities (Q)
$8.13M
Book Value Per Share (Q)
$1.29
Cash Flow
Cash from Operations (TTM)
-$32.71M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$25.99M
Net Change in Cash (TTM)
-$6.67M
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
0.65
7-Day Total Return
-1.75%
30-Day Total Return
8.47%
60-Day Total Return
-7.01%
90-Day Total Return
22.59%
Year to Date Total Return
48.07%
1-Year Total Return
-27.87%
2-Year Total Return
-3.82%
3-Year Total Return
0.41%
5-Year Total Return
21.46%
52-week Low
Dec 20, 2024 - $4.32
52-week High
May 23, 2024 - $10.70
Valuation
Market Cap
$174.08M - Micro Cap
Enterprise Value
$155.09M
Price/Sales (TTM)
3,409.09
Price/Book (Q)
5.80
Dividends and Shares
Shares Outstanding
22.50M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.inmunebio.com
Phone Number
858 964 3720
Address
225 NE Mizner Blvd.
Boca Raton, FL 33432
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and... more
NASDAQ 05/23/2025 4:00PM Eastern Quotes delayed